Table 8.
Baseline frequency of co-morbidities in trial participants
| NPWT (n = 6) | SC (n = 6) | ||
|---|---|---|---|
|
Co-morbidity |
Frequency(n) |
Co-morbidity |
Frequency(n) |
| Faecal incontinence |
4 |
Faecal incontinence |
3 |
| Myocardial infarction |
3 |
Multiple sclerosis |
2 |
| Non-insulin dependent diabetes mellitus |
3 |
Spinal injury |
2 |
| Angina |
2 |
Urinary incontinence |
1 |
| Heart failure |
2 |
Other cardiovascular disease |
1 |
| Rheumatoid arthritis |
2 |
Insulin-dependent diabetes mellitus |
1 |
| Chronic obstructive pulmonary airways/pulmonary disease |
2 |
Femoral neck fracture |
1 |
| Stroke |
2 |
Chronic obstructive pulmonary airways/pulmonary disease |
1 |
| Urinary incontinence |
1 |
Other neurological |
2 |
| Ischaemia (leg/foot) |
1 |
Myocardial infarction |
0 |
| Insulin-dependent diabetes mellitus |
1 |
Angina |
0 |
| Multiple sclerosis |
1 |
Heart failure |
0 |
| Other |
1 (lymphoedema) |
Ischaemia (leg/foot) |
0 |
| Other cardiovascular disease |
0 |
Non-insulin-dependent diabetes mellitus |
0 |
| Femoral neck fracture |
0 |
Rheumatoid arthritis |
0 |
| Spinal injury |
0 |
Stroke |
0 |
| Other neurological |
0 |
Other |
0 |
| Total co-morbidities | 25 | Total co-morbidities | 14 |
Co-morbidities are ranked in order of descending frequency in each treatment group.